U.S. Markets open in 8 hrs 3 mins

U.S. FDA approves GSK's two-drug HIV treatment

April 8 (Reuters) - The U.S. Food and Drug Administration said on Monday it had approved GlaxoSmithKline Plc's two-drug HIV treatment.

The approval was granted to GSK's majority-owned HIV unit ViiV Healthcare, the FDA said. (Reporting by Manas Mishra in Bengaluru; Editing by Shounak Dasgupta)